ID: ALA4638657

Max Phase: Preclinical

Molecular Formula: C17H32O2

Molecular Weight: 268.44

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCC(C(=O)O)C1CCCCC1

Standard InChI:  InChI=1S/C17H32O2/c1-2-3-4-5-6-7-11-14-16(17(18)19)15-12-9-8-10-13-15/h15-16H,2-14H2,1H3,(H,18,19)

Standard InChI Key:  IKYFLGJYPFKGKG-UHFFFAOYSA-N

Associated Targets(non-human)

Mycobacterium leprae 477 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 268.44Molecular Weight (Monoisotopic): 268.2402AlogP: 5.41#Rotatable Bonds: 10
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.98CX Basic pKa: CX LogP: 6.18CX LogD: 3.79
Aromatic Rings: 0Heavy Atoms: 19QED Weighted: 0.54Np Likeness Score: 0.74

References

1. Bera S, Mondal D..  (2019)  Insights of synthetic analogues of anti-leprosy agents.,  27  (13): [PMID:31103404] [10.1016/j.bmc.2019.04.032]

Source